Purdue payments to Sackler family surged after OxyContin fine
Family started taking far more money out of firm after it was fined for misleading marketing of drug
The wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined for misleading marketing of the powerful prescription painkiller.
Purdue made payments for the benefit of members of the Sackler family totalling $10.7bn (£8bn) from 2008 through to 2017, a court filing made by the company on Monday evening shows.